Providence Veterans Affairs Medical Center
Providence, Rhode Island, 02908, United States
NCT Number: NCT00352937
To compare the efficacy of 16-row multi-detector CT (MDCT) with standard myocardial perfusion imaging in detecting coronary artery disease (CAD) in patients without a previously established diagnosis of CAD.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Providence, Rhode Island, 02908, United States
Nuclear stress testing is currently the established non-invasive modality in detecting flow-obstructing coronary artery disease (CAD).
Recently, multi-detector CT (MDCT) has emerged as a new modality that offers a non-invasive means to directly visualize coronary anatomy and any CAD. Studies have shown that MDCT has excellent sensitivity and a high negative predictive value in detecting significant CAD.
The purpose of this study is to compare MDCT with nuclear stress testing for detecting CAD in previously undiagnosed patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Providence VA Medical Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06299735
Arterial Occlusive Diseases, Arteriosclerosis
Ankara, Çankaya, Turkey (Türkiye)
View Trial DetailsNCT01777503
Acute Coronary Syndrome, Arterial Occlusive Diseases
Reggio Emilia, Italy
View Trial DetailsNCT00129038
Arterial Occlusive Diseases, Arteriosclerosis
Dublin, Ireland
View Trial DetailsNCT00357955
Arterial Occlusive Diseases, Arteriosclerosis
Providence, Rhode Island, United States
View Trial Details